NEW YORK (GenomeWeb News) - The BioAnalytics Group said last week that it is collaborating with Prescient Medical to develop heart attack prevention and treatment technologies.
Under the agreement, the BioAnalytics Group will use its Model Based Assay biosimulation methodologies to help Prescient calibrate and optimize a Raman Spectroscopy-based diagnostic system to characterize vulnerable plaque.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

CNN reports that researchers have tied a new variant to opioid addiction risk.

Organoids derived from patients' tumors may help determine what chemotherapy treatment patients would benefit from, according to New Scientist.

An initiative from GenomeAsia 100K hopes to increase the number of South Asians in genetic research, according to NBC News.

In Science this week: genomic analysis of ancient and modern horses indicates population turnover, and more.